PRN: Global $6.6 Bn In-Vitro Diagnostics (IVD) Packaging Market, 2022

15/set/2017 11:00:17 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global $6.6 Bn In-Vitro Diagnostics (IVD) Packaging Market, 2022


DUBLIN, Sept. 15, 2017 /PRNewswire/ --

The "Global In-Vitro Diagnostics (IVD) Packaging Market - By Technology, Product, End User, Application, Region - Market Size, Demand Forecasts, Industry Trends and Updates (2016-2022)" report has been added to Research and Markets' offering.

Research and Markets Logo

The global market for In vitro diagnostics packaging was USD 6.62 billion in 2016 and is estimated to reach USD 8.16 billion by 2022 at a CAGR of 3.49% during the period.

In vitro diagnostics (IVD) is a medical device used for performing tests on specimens like blood, urine, stool and other body fluids, derived from humans to detect diseases and infections. This is essential for early diagnosis and treatment of chronic diseases. Increasing number of point of care testing is one of the major drivers of the market. Recent advancements in IVD increase the quality and functionality of packaging materials without affecting the production cost.

The significant market growth observed in emerging countries is the key driver for the growth of this market

The bottles and vials among various products is expected to share highest revenue in the upcoming years because of its ability to withstand high temperatures, thermal and chemical shocks and high adaptability to various IVD techniques.

The significant market growth observed in emerging countries is the key driver for the growth of this market. Emerging economies, such as Brazil, Russia, India, and China (BRIC), re the focus regions for the period. The improvement of the existing healthcare infrastructure in these countries will result in the augmented demand for IVD packaging during the forecast period.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

  • Definition
  • Industry Value Chain Analysis
  • Porter's 5 Forces
  • Regulations

4. Market Dynamics

  • Introduction
  • Drivers
  • Constraints
  • Opportunities

5. Global In-Vitro Diagnostics (IVD) Packaging market Segmentation, Forecasts and Trends - By Revenue

6. By Technology

  • Clinical Chemistry
  • Immunoassay
  • Microbiology
  • Hematology
  • Molecular Diagnostics
  • Coagulation
  • Point of Care Testing (POCT)
  • Others

7. By Product

  • Instruments
  • Consumables
  • Others

8. By End User

  • Academics
  • Laboratories
  • POCT
  • Biotechnology/Pharmaceuticals

9. By Application

  • Diabetes
  • Cancer
  • Cardiology
  • Autoimmune Diseases
  • Drug Testing
  • Others

10. By Region

  • North America
  • US
  • Canada
  • Europe
  • UK
  • France
  • Germany
  • Italy
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Others
  • Middle East and Africa
  • United Arab Emirates
  • Saudi Arabia
  • South Africa
  • Others

11. Vendor Market Share Analysis

12. Company Profiles

  • Abbott Laboratories
  • Roche Diagnostics
  • Danaher Corporation
  • Alere Incorporated
  • Bayer AG
  • BioRad Laboratories
  • Johnson & Johnson
  • Becton Dickinson & Company
  • Biomerieux
  • Bristol-Myers Squibb Company
  • Siemen's Health care
  • Thermo Fisher Scientific
  • Others

13. Industry Structure

  • Industry M&As, Consolidations
  • Investment Opportunities
  • Global In-Vitro Diagnostics (IVD) Packaging market - Road Ahead
  • Tables

For more information about this report visit

Media Contact:
Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus è un servizio offerto da Factotum Srl